Randomised Control Trial to Compare the Effects of G-CSF and Autologous Bone Marrow Progenitor Cells Infusion on the Quality of Life and Left Ventricular Function in Patients With Heart Failure Secondary to Ischaemic Heart Disease.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bone marrow cell therapy (Primary) ; Granulocyte colony-stimulating factors
- Indications Chronic heart failure
- Focus Therapeutic Use
- Acronyms REGEN-IHD; REGENERATE-IHD
- 09 Oct 2013 Biomarkers information updated
- 04 Mar 2013 Last checked against ISRCTN: Current Controlled Trials record.
- 20 Aug 2012 Planned end date changed from 1 Dec 2012 to 1 May 2013 as reported by ClinicalTrials.gov.